A follow up study by the McWilliams group again found a significant increase in pancreatic cancer in carriers of the CFTR gene (5.3% versus 3.8%) along with a younger average onset (62 versus 67 years) [67]. This evidence concerns the gene CFTR and pancreatic neoplasm.